logo

For the Inventor, By the Inventor

King of Prussia, PA, United States of America

Hong Nie

This inventor holds 14 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Smithkline Beecham Corporation, Glaxosmithkline Intellectual Property Development Limited, Astex Therapeutics Limited. Active years: 1999-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Nie. Retrieved from https://idiyas.com/inventor/hong-nie-dvk2x26y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 57.1

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 96(Granted Patents)


Location History:

  • Conshohocken, PA (US) (1999 - 2004)
  • King of Prussia, PA (US) (2010 - 2021)

Company Filing History:

goldMedal9 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal3 out of 242 
 
Glaxosmithkline Intellectual Property Development Limited
 patents
bronzeMedal2 out of 126 
 
Astex Therapeutics Limited
 patents
4. 1 out of 8 
 
Glaxogrouplimited
 patents
5. 1 out of 358 
 
Glaxosmithkline LLC
 patents
where one patent can have more than one assignee

Years Active: 1999-2021

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 11078216 - Bisaryl amides as NRF2 activators (2021-08-03),
2. 10364256 - Biaryl pyrazoles as NRF2 regulators (2019-07-30),
3. 10351530 - Arylcyclohexyl pyrazoles as NRF2 regulators (2019-07-16),
4. 8354406 - Chemical compounds (2013-01-15),
5. 7858796 - Chemical compounds (2010-12-28),
6. 6680317 - IL-8 receptor antagonists (2004-01-20),
7. 6653310 - IL-8 receptor antagonists (2003-11-25),
8. 6436927 - IL-8 receptor antagonists (2002-08-20),
9. 6316478 - IL-8 receptor antagonists (2001-11-13),
10. 6297265 - Benzoisothiazole-substituted compounds useful as IL-8 receptor antagonists (2001-10-02),
11. 6166055 - Benzoisothiazole compounds useful as IL-8 receptor antagonists (2000-12-26),
12. 6043374 - Benzisothiazolidine Compounds (2000-03-28),
13. 6015908 - IL-8 receptor antagonists (2000-01-18),
14. 5929250 - IL-8 receptor antagonists (1999-07-27),

Title: The Innovative Contributions of Hong Nie

Introduction

Hong Nie is a prominent inventor based in King of Prussia, Pennsylvania, known for his significant contributions to the field of pharmaceutical sciences. With a total of 14 patents to his name, he has made remarkable advancements in the development of NRF2 activators and regulators.

Latest Patents

Among his latest patents, Nie has developed bisaryl amides as NRF2 activators. This invention relates to bisaryl amide analogs, pharmaceutical compositions containing them, and their use as NRF2 activators. In particular, the invention focuses on bisaryl heterocycles of Formula (I). Another notable patent is for biaryl pyrazoles as NRF2 regulators. This invention encompasses biaryl pyrazole compounds of Formula (I), methods of making them, pharmaceutical compositions containing them, and their application as NRF2 regulators.

Career Highlights

Throughout his career, Hong Nie has worked with esteemed organizations such as SmithKline Beecham Corporation and GlaxoSmithKline Intellectual Property Development Limited. His work in these companies has significantly contributed to the advancement of pharmaceutical innovations.

Collaborations

Nie has collaborated with notable coworkers, including Katherine L. Widdowson and Jeffrey K. Kerns, further enhancing his research and development efforts in the pharmaceutical field.

Conclusion

Hong Nie's innovative work and numerous patents highlight his dedication to advancing pharmaceutical sciences. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…